explore -WSS

explore

author：knowledge 2025-09-28 01:38:23 - browse：23

WICHITA, Kan. -- A second suspect is now in custody in connection with a mass shooting that injured nearly a dozen people earlier this month in Kansas, Wichita police announced Monday.

A 27-year-old man was arrested on suspicion of aggravated battery and possession of a firearm by a felon. On Friday, a 19-year-old man was arrested. It wasn't immediately clear if either man has been charged. Their names have not been released. A message left with Sedgwick County District Attorney Marc Bennett wasn't immediately returned.

The shooting happened in the early hours of July 2 at City Nightz in downtown Wichita. Nine people were shot and two others were trampled in the chaos that followed. No one died.

In addition to the arrests, police are searching for a 23-year-old man believed to have been involved in the shooting. A St. Louis-area man was arrested July 3, but prosecutors later determined he fired his gun to defend himself after shots were fired by two other men at the club.

The gunshot victims — seven men and two women — ranged in age from 22 to 34, police said. The two people trampled were a 30-year-old woman and a 31-year-old male.

Wichita is a city of nearly 400,000 people, located about 200 miles (320 kilometers) southwest of Kansas City, Missouri.

Previous article： Cancer drug shortages should be causing more outrage
Next article： Generate Biomedicines machine learning biotech raises $273M

WSS

WATCH: Why do bright lights make us see spots?

UnitedHealth’s Optum accused of antitrust violations in California

Popular nasal decongestant doesn't actually relieve congestion

How medical schools plan to diversify without affirmative action

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

PEPFAR is under serious threat — and so is global health

Wikipedia

explore

hotspot

Supreme Court strikes down use of affirmative action

WATCH: Why do bright lights make us see spots?

Dobbs anniversary: the lost opportunity of abortion as health care

Private equity could exacerbate cardiology's overuse problem, experts fear

After affirmative action ruling, medical educators look to 'holistic review'

White House touts steps to stem shortages of cancer treatments

Activists slam private health insurers over coverage restrictions

30 years of 'Listening to Prozac'

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

As biotech industry slumps, bioscience job market is upside down

Wikipedia

CDC director unscathed in first congressional testimony

FDA proposes changes to key medical devices approval pathway

Disappointing trial forces Pfizer to pivot on obesity medicine plans

J&J to emphasize cancer drugs, stop much of its vaccine research

FDA panel endorses Alnylam’s heart drug — after picking it apart

Popular nasal decongestant doesn't actually relieve congestion

explore

explore

hotspot

leisure time